Sorrento Therapeutics Invests In New Company, Celularity
socalTECH
AUGUST 22, 2017
San Diego-based biopharmaceuticals developer Sorrento Therapeutics announced on Monday that it has invested in a newly former company, Celularity , focused on treatment of cancer, inflammatory and degenerative diseases, and functional regeneration using placental technology. Sorrento said it will make a capital investment, and also provide certain immuno-oncology and cellular therapy intellectual property and assets to Celularity.
Let's personalize your content